Intec flunks phase 3 Parkinson’s test against Merck drug – FierceBiotech

Intec flunks phase 3 Parkinson’s test against Merck drug – FierceBiotech
Intec flunks phase 3 Parkinson's test against Merck drug  FierceBiotechA phase 3 trial of Intec Pharma's Parkinson's disease drug has missed its primary endpoint, sparking a steep decline in the company's stock. The candidate uses ... read more
Source: Google NewsPublished on 2019-07-22